NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lorus Therapeutics Inc. 

2 Meridian Road

Toronto  Ontario  M9W 4Z7  Canada
Phone: 416-798-1200 Fax: 416-798-2200


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Lorus Therapeutics Inc. (LRP) Reports First Quarter Results for Fiscal Year 2010 10/6/2009 10:51:13 AM    More...
Lorus Therapeutics Inc. (LRP) Announces Publication Supporting Novel Mode of Anticancer Therapy for LOR-253 Class of Compounds 9/21/2009 11:19:07 AM    More...
Lorus Therapeutics Inc. (LRP) Announces Allowance of Patent for LOR-2040 in Japan 8/5/2009 10:40:20 AM    More...
Lorus Therapeutics Inc. (LRP) Reports Results for Fiscal Year 2009 7/27/2009 9:46:25 AM    More...
Lorus Therapeutics Inc. (LRP) Announces Publication of a Novel Analytical Method Confirming the Pharmacological Action of Its Anticancer Drug LOR-2040 6/29/2009 11:12:14 AM    More...
Lorus Therapeutics Inc. (LRP) Announces Settlement of Secured Convertible Debentures 6/23/2009 11:26:01 AM    More...
Lorus Therapeutics Inc. (LRP) Announces a Cooperative Research and Development Agreement With the U.S. National Cancer Institute 5/19/2009 11:13:04 AM    More...
Lorus Therapeutics Inc. (LRP) Announces Presentation of New Supportive Data for LOR-2040 in Acute Myeloid Leukemia 4/22/2009 11:00:36 AM    More...
Lorus Therapeutics Inc. (LRP) Presents New Findings for First-in-class Anticancer Drug Candidate LOR-253 4/20/2009 10:54:14 AM    More...
Lorus Therapeutics Inc. (LRP) Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors 4/15/2009 10:38:23 AM    More...
12345678910...